Furthermore, it was reported that transgenic introduction of human sclerostin could inhibit inflammatory cytokines and chemokines, while prevent AA and atherosclerosis progression in ApoE-/- mice with AngII infusion 12. Here, APOE is linked to atherosclerosis.